FDA Plays

[colorofmoney]

BIEL News...BioElectronics Announces New Product Offerings and Enhancements to Target the
Japanese Marketplace

FREDERICK, MD, Jun 17, 2010 (MARKETWIRE via COMTEX) -- BioElectronics Corporation
(PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free
anti-inflammatory devices, and YesDTC Holdings (YESD), BioElectronics' exclusive
distributor in Japan, today announced several important product line enhancements
specifically tailored to suit the needs of the highly discerning and
quality-conscious Japanese marketplace. These enhancements include requested
modifications to the Allay(TM) Menstrual Pain Therapy and ActiPatch(TM) brands of
products. Additionally, upon release, BioElectronics will make the recently
announced back pain belt available first to the Japanese marketplace.

"We are very excited about our prospects within the Japanese market as both its
medical practitioners and consumers are typically highly accepting of new
treatment therapies. This, combined with the robustness of the economy and the
favorable regulatory climate, leads us to believe Japan could easily be one of
the most robust markets for our drug-free, anti-inflammatory and pain relieving
technologies," commented Georgianna Golematis, Allay Brand Manager at
BioElectronics. "We are excited to begin offering these product enhancements and
to soon offer this new product to the Japanese marketplace."

Enhancements to the Allay product line will include a significantly improved
on/off switch that will allow women to easily preserve battery life to enable use
of the product for at least 10 menstrual cycles. Additionally, based on feedback
from BioElectronics' Japanese distribution partners, several other important
hygienic and aesthetic features of the product are being modified to better fit
the Japanese marketplace. The ActiPatch product will also see modifications,
which will include the fitting of new and stronger, flexible and breathable
fabrics to ensure better fit and comfort.

Management of BioElectronics recently announced a revolutionary back pain belt,
specifically designed to offer a safer alternative therapy for the approximately
80% of adults who suffer from this ailment. Due to favorable Japanese regulatory
environment, combined with the sheer size of the Japanese economy, BioElectronics
has agreed with its Japanese distribution partner to use Japan as one of its test
beds for not only these new devices, but also for the enhanced Allay and
ActiPatch product offerings.

About BioElectronics Corporation BioElectronics Corporation (PINKSHEETS: BIEL) is
the maker of safe, inexpensive, drug-free medical devices and patches that
deliver pulsed electromagnetic energy to relieve pain and inflammation. The
company's wafer thin patches contain an embedded microchip and battery that
deliver pulsed electromagnetic energy, a clinically proven and widely accepted
anti-inflammatory and pain relief therapy that heretofore has only been possible
to obtain from large, facility-based equipment. BioElectronics markets and sells
its current products under the brand names ActiPatch(R), RecoveryRx(TM),
Allay(TM) Menstrual Pain Therapy and HealFast(TM) Therapy for cats, dogs and
horses. The company is headquartered in Frederick, MD. For more information,
visit http://www.bielcorp.com.